Trial Outcomes & Findings for Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment (NCT NCT05618912)

NCT ID: NCT05618912

Last Updated: 2024-12-11

Results Overview

Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

146 participants

Primary outcome timeframe

7 days

Results posted on

2024-12-11

Participant Flow

Participant milestones

Participant milestones
Measure
Hydrocolloid Dressing Arm
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Overall Study
STARTED
72
74
Overall Study
COMPLETED
58
55
Overall Study
NOT COMPLETED
14
19

Reasons for withdrawal

Reasons for withdrawal
Measure
Hydrocolloid Dressing Arm
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Overall Study
Lost to Follow-up
14
19

Baseline Characteristics

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hydrocolloid Dressing Arm
n=72 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
n=74 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Total
n=146 Participants
Total of all reporting groups
Age, Continuous
63.8 years
STANDARD_DEVIATION 11.5 • n=5 Participants
61.3 years
STANDARD_DEVIATION 13.5 • n=7 Participants
61.9 years
STANDARD_DEVIATION 12.9 • n=5 Participants
Sex: Female, Male
Female
40 Participants
n=5 Participants
45 Participants
n=7 Participants
85 Participants
n=5 Participants
Sex: Female, Male
Male
32 Participants
n=5 Participants
29 Participants
n=7 Participants
61 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
72 Participants
n=5 Participants
73 Participants
n=7 Participants
145 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 7 days

Population: The above numbers reflect the number of patients who responded at 7-day postoperative followup and is smaller than the original number of participants in each arm due to lack of response by some participants

Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.

Outcome measures

Outcome measures
Measure
Hydrocolloid Dressing Arm
n=64 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
n=65 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Cosmetic Outcome
Surgeons - Scar Line
6.48 score on a scale
Standard Error 0.12
6.30 score on a scale
Standard Error 0.12
Cosmetic Outcome
Patients - Overall
7.4 score on a scale
Standard Error 2.0
6.6 score on a scale
Standard Error 1.9
Cosmetic Outcome
Surgeons - Overall
6.3 score on a scale
Standard Error 1.7
6.00 score on a scale
Standard Error 1.8
Cosmetic Outcome
Patients - Color
7.1 score on a scale
Standard Error 1.8
6.6 score on a scale
Standard Error 1.8
Cosmetic Outcome
Surgeons - Color
6.44 score on a scale
Standard Error 0.13
5.97 score on a scale
Standard Error 0.14
Cosmetic Outcome
Patients - Texture
6.8 score on a scale
Standard Error 2.0
6.4 score on a scale
Standard Error 2.0
Cosmetic Outcome
Surgeons - Texture
5.83 score on a scale
Standard Error 0.16
5.80 score on a scale
Standard Error 0.15
Cosmetic Outcome
Patients - Scar Line
7.0 score on a scale
Standard Error 2.1
6.4 score on a scale
Standard Error 2.1

PRIMARY outcome

Timeframe: 30 days

Population: The above numbers reflect the number of patients who responded at 30-day postoperative followup and is smaller than the original number of participants in each arm and the number of participants analyzed at 7-day followup due to lack of response by some participants

Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.

Outcome measures

Outcome measures
Measure
Hydrocolloid Dressing Arm
n=64 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
n=60 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Cosmetic Outcome
Patients - Overall
7.6 score on a scale
Standard Error 1.5
7.6 score on a scale
Standard Error 1.9
Cosmetic Outcome
Surgeons - Overall
7.07 score on a scale
Standard Error 0.13
7.00 score on a scale
Standard Error 0.14
Cosmetic Outcome
Surgeons - Color
7.17 score on a scale
Standard Error 0.14
7.21 score on a scale
Standard Error 0.15
Cosmetic Outcome
Patients - Texture
7.0 score on a scale
Standard Error 1.6
6.4 score on a scale
Standard Error 2.1
Cosmetic Outcome
Surgeons - Texture
6.48 score on a scale
Standard Error 0.12
6.30 score on a scale
Standard Error 0.12
Cosmetic Outcome
Patients - Scar Line
7.3 score on a scale
Standard Error 1.7
7.3 score on a scale
Standard Error 2.1
Cosmetic Outcome
Surgeons - Scar Line
7.04 score on a scale
Standard Error 0.14
6.95 score on a scale
Standard Error 0.14
Cosmetic Outcome
Patients - Color
7.5 score on a scale
Standard Error 1.5
7.5 score on a scale
Standard Error 1.8

PRIMARY outcome

Timeframe: 90 days

Population: The above numbers reflect the number of patients who responded at 90-day postoperative followup and is smaller than the number of participants initially enrolled and the number analyzed at 7-day and 30-day followup due to lack of response by some participants

Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.

Outcome measures

Outcome measures
Measure
Hydrocolloid Dressing Arm
n=58 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
n=55 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Cosmetic Outcome
Patients - Overall
8.2 score on a scale
Standard Error 1.8
8.1 score on a scale
Standard Error 1.6
Cosmetic Outcome
Surgeons - Color
6.44 score on a scale
Standard Error 0.13
5.97 score on a scale
Standard Error 0.14
Cosmetic Outcome
Patients - Texture
8.1 score on a scale
Standard Error 1.7
7.8 score on a scale
Standard Error 2.0
Cosmetic Outcome
Surgeons - Texture
8.28 score on a scale
Standard Error 0.11
8.14 score on a scale
Standard Error 0.12
Cosmetic Outcome
Patients - Scar Line
8.1 score on a scale
Standard Error 1.9
7.9 score on a scale
Standard Error 2.1
Cosmetic Outcome
Surgeons - Scar Line
7.89 score on a scale
Standard Error 0.13
7.86 score on a scale
Standard Error 0.13
Cosmetic Outcome
Surgeons - Overall
7.94 score on a scale
Standard Error 0.12
7.92 score on a scale
Standard Error 0.12
Cosmetic Outcome
Patients - Color
7.1 score on a scale
Standard Error 1.8
6.6 score on a scale
Standard Error 1.8

SECONDARY outcome

Timeframe: 7 days, 30 days, 90 days

Complication rate including hematoma, seroma, wound infection requiring antibiotics, opening and drainage of wound, dehiscence. Complications will be assessed by physicians other than operating surgeon

Outcome measures

Outcome measures
Measure
Hydrocolloid Dressing Arm
n=72 Participants
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
n=74 Participants
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Number of Participants With Complications
Itching
29 Participants
28 Participants
Number of Participants With Complications
Surgical site pain
14 Participants
7 Participants
Number of Participants With Complications
Required antibiotics
0 Participants
0 Participants
Number of Participants With Complications
Wound dehiscence
4 Participants
0 Participants
Number of Participants With Complications
Post-op bleeding
13 Participants
5 Participants

Adverse Events

Hydrocolloid Dressing Arm

Serious events: 0 serious events
Other events: 60 other events
Deaths: 0 deaths

Petrolatum Jelly Dressing Arm

Serious events: 0 serious events
Other events: 40 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Hydrocolloid Dressing Arm
n=72 participants at risk
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental) Hydrocolloid dressing: A single hydrocolloid dressing will be applied to the surgical site for 7 days following dermatologic surgery
Petrolatum Jelly Dressing Arm
n=74 participants at risk
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily. Petrolatum jelly dressing: The patient with the control wound will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Skin and subcutaneous tissue disorders
Itching
40.3%
29/72 • Number of events 29 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
37.8%
28/74 • Number of events 28 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
Skin and subcutaneous tissue disorders
Surgical site pain
19.4%
14/72 • Number of events 14 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
9.5%
7/74 • Number of events 7 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
Skin and subcutaneous tissue disorders
Required antibiotics
0.00%
0/72 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
0.00%
0/74 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
Skin and subcutaneous tissue disorders
Wound dehiscence
5.6%
4/72 • Number of events 4 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
0.00%
0/74 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
Skin and subcutaneous tissue disorders
Post-op bleeding
18.1%
13/72 • Number of events 13 • Adverse event data were collected over a 90-day period following the patient's excisional surgery
6.8%
5/74 • Number of events 5 • Adverse event data were collected over a 90-day period following the patient's excisional surgery

Additional Information

Dr. Syril Keena T. Que

Indiana University School of Medicine

Phone: 317-944-7744

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place